Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment.

Griggs JJ, Sorbero ME, Ahrendt GM, Stark A, Heininger S, Gold HT, Schiffhauer LM, Dick AW.

Med Care. 2009 Jul;47(7):749-57. doi: 10.1097/MLR.0b013e31819748b3.

2.

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.

Coromilas EJ, Wright JD, Huang Y, Feldman S, Neugut AI, Chen L, Hershman DL.

JAMA Oncol. 2015 Jun;1(3):323-32. doi: 10.1001/jamaoncol.2015.0389.

PMID:
26181180
3.

Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.

van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV.

Breast. 2014 Feb;23(1):63-8. doi: 10.1016/j.breast.2013.11.001. Epub 2013 Dec 2.

PMID:
24291376
4.

Trends in the treatment of ductal carcinoma in situ of the breast.

Baxter NN, Virnig BA, Durham SB, Tuttle TM.

J Natl Cancer Inst. 2004 Mar 17;96(6):443-8.

PMID:
15026469
5.

Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.

Greenberg CC, Lipsitz SR, Hughes ME, Edge SB, Theriault R, Wilson JL, Carter WB, Blayney DW, Niland J, Weeks JC.

Ann Surg. 2011 Aug;254(2):339-45. doi: 10.1097/SLA.0b013e3182263bb0.

6.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
7.

Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.

Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ.

J Natl Cancer Inst. 2011 Jan 19;103(2):92-104. doi: 10.1093/jnci/djq499. Epub 2011 Jan 3.

8.

Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.

Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC.

Surgery. 2016 Apr;159(4):1199-209. doi: 10.1016/j.surg.2015.11.001. Epub 2015 Dec 17.

PMID:
26704783
9.

Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.

Wasserberg N, Morgenstern S, Schachter J, Fenig E, Lelcuk S, Gutman H.

Arch Surg. 2002 Nov;137(11):1249-52.

PMID:
12413311
10.

Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.

Frasier LL, Holden S, Holden T, Schumacher JR, Leverson G, Anderson B, Greenberg CC, Neuman HB.

JAMA Oncol. 2016 Jan;2(1):95-101. doi: 10.1001/jamaoncol.2015.3717. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.

11.

Do not contemplate invasive surgery for ductal carcinoma in situ.

Zelis JJ, Sickle-Santanello BJ, Liang WC, Nims TA.

Am J Surg. 2002 Oct;184(4):348-9.

PMID:
12383899
12.

Patterns and correlates of local therapy for women with ductal carcinoma-in-situ.

Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, Deapen D, Salem B, Lakhani I, Morrow M.

J Clin Oncol. 2005 May 1;23(13):3001-7.

13.

Variations in treatment for ductal carcinoma in situ in elderly women.

Gold HT, Dick AW.

Med Care. 2004 Mar;42(3):267-75.

PMID:
15076826
14.

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.

Tunon-de-Lara C, Chauvet MP, Baranzelli MC, Baron M, Piquenot J, Le-Bouédec G, Penault-Llorca F, Garbay JR, Blanchot J, Mollard J, Maisongrosse V, Mathoulin-Pélissier S, MacGrogan G.

Ann Surg Oncol. 2015 Nov;22(12):3853-60. doi: 10.1245/s10434-015-4476-5. Epub 2015 Mar 17.

15.

Is Sentinel Lymph Node Dissection Necessary in All Patients with Ductal Carcinoma In Situ Undergoing Total Mastectomy?

Bonev V, De Paz Villanueva CC, Solomon N, Senthil M, Reeves ME, Garberoglio C, Lum SS.

Am Surg. 2016 Oct;82(10):982-984.

PMID:
27779988
16.

Ductal carcinoma in situ: value of sentinel lymph node biopsy.

Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S.

J Surg Oncol. 2006 Oct 1;94(5):426-30. Review.

PMID:
16967457
17.

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.

Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.

PMID:
17597346
18.
19.

Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.

Porembka MR, Abraham RL, Sefko JA, Deshpande AD, Jeffe DB, Margenthaler JA.

Ann Surg Oncol. 2008 Oct;15(10):2709-19. doi: 10.1245/s10434-008-9947-5. Epub 2008 May 16.

PMID:
18483831
20.

Supplemental Content

Support Center